These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2598172

  • 1. Initial immunochemical characterization of specific macrophage-arming factor.
    De Weger RA, Vandebriel RJ, Slager H, Mans D, Van Loveren H, Wilbrink B, Dullens HF, Den Otter W.
    Cancer Immunol Immunother; 1989; 30(1):21-7. PubMed ID: 2598172
    [Abstract] [Full Text] [Related]

  • 2. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW, De Weger RA, Vandebriel RJ, Den Otter W.
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [Abstract] [Full Text] [Related]

  • 3. Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.
    Dullens HF, De Weger RA, Van der Maas M, Den Besten PJ, Vandebriel RJ, Den Otter W.
    Cancer Immunol Immunother; 1989 Jun; 30(1):28-33. PubMed ID: 2598173
    [Abstract] [Full Text] [Related]

  • 4. Two specific T cell factors that initiate immune responses in murine allograft systems. A comparison of biologic functions.
    Vandebriel RJ, De Weger RA, Los G, Van Loveren H, Wiegers GJ, Oude Weernink PA, Den Otter W.
    J Immunol; 1989 Jul 01; 143(1):66-73. PubMed ID: 2659669
    [Abstract] [Full Text] [Related]

  • 5. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.
    Evans R, Grant CK, Cox H, Steele K, Alexander P.
    J Exp Med; 1972 Nov 01; 136(5):1318-22. PubMed ID: 4117192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
    Pels E, De Weger RA, Den Otter W.
    Int Arch Allergy Appl Immunol; 1984 Nov 01; 74(2):140-6. PubMed ID: 6609130
    [Abstract] [Full Text] [Related]

  • 8. Specific T-cell factors that initiate cellular immune responses are produced by CD4-, CD8-, V beta 8- lymphocytes and are present in nude mice.
    Vandebriel RJ, De Weger RA, Van Loveren H, Garssen J, Van Poppel MN, Van Wichen DF, Den Otter W.
    Cell Immunol; 1994 Nov 01; 159(1):1-14. PubMed ID: 7954837
    [Abstract] [Full Text] [Related]

  • 9. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
    De Weger RA, Pels E, Den Otter W.
    Immunology; 1982 Nov 01; 47(3):541-50. PubMed ID: 6215342
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular mass analysis of murine immunosuppressive immunoglobulin G-binding factors (IgG-BFs) produced by T-cell hybrids.
    Néauport-Sautès C, Gelabert MJ, Moncuit J, Fridman WH.
    FEBS Lett; 1984 Jun 04; 171(1):41-5. PubMed ID: 6609841
    [Abstract] [Full Text] [Related]

  • 14. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE, Grabstein KH, Okuno K, Schreiber RD, Greenberg PD.
    J Immunol; 1989 Dec 15; 143(12):4308-16. PubMed ID: 2687379
    [Abstract] [Full Text] [Related]

  • 15. T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.
    Sypek JP, Wyler DJ.
    Infect Immun; 1990 May 15; 58(5):1146-52. PubMed ID: 2323812
    [Abstract] [Full Text] [Related]

  • 16. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation.
    Iwata M, Adachi M, Ishizaka K.
    J Immunol; 1988 Apr 15; 140(8):2534-42. PubMed ID: 3258613
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS, Benjamin WR, Farrar JJ.
    J Immunol; 1982 Dec 15; 129(6):2802-7. PubMed ID: 6982943
    [Abstract] [Full Text] [Related]

  • 19. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.
    Farrar WL, Mizel SB, Farrar JJ.
    J Immunol; 1980 Mar 15; 124(3):1371-7. PubMed ID: 6153680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.